BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26032092)

  • 1. Curcumin inhibits growth of prostate carcinoma via miR-208-mediated CDKN1A activation.
    Guo H; Xu Y; Fu Q
    Tumour Biol; 2015 Nov; 36(11):8511-7. PubMed ID: 26032092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginsenoside Rh2 inhibits prostate cancer cell growth through suppression of microRNA-4295 that activates CDKN1A.
    Gao Q; Zheng J
    Cell Prolif; 2018 Jun; 51(3):e12438. PubMed ID: 29457293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-3619-5p inhibits prostate cancer cell growth by activating CDKN1A expression.
    Li S; Wang C; Yu X; Wu H; Hu J; Wang S; Ye Z
    Oncol Rep; 2017 Jan; 37(1):241-248. PubMed ID: 27878260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-639 promoted cell proliferation and cell cycle in human thyroid cancer by suppressing CDKN1A expression.
    Lei ST; Shen F; Chen JW; Feng JH; Cai WS; Shen L; Hu ZW; Xu B
    Biomed Pharmacother; 2016 Dec; 84():1834-1840. PubMed ID: 27829546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of miR-20a on p21: Two Mechanisms Blocking Growth Arrest in TGF-β-Responsive Colon Carcinoma.
    Sokolova V; Fiorino A; Zoni E; Crippa E; Reid JF; Gariboldi M; Pierotti MA
    J Cell Physiol; 2015 Dec; 230(12):3105-14. PubMed ID: 26012475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of hepatocellular carcinoma tumorigenesis by curcumin may be associated with CDKN1A and CTGF.
    Zeng Y; Shen Z; Gu W; Wu M
    Gene; 2018 Apr; 651():183-193. PubMed ID: 29408622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
    Wu Z; He B; He J; Mao X
    Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of miR-34a in curcumin-induced antiproliferation of prostate cancer cells.
    Zhu M; Zheng Z; Huang J; Ma X; Huang C; Wu R; Li X; Liang Z; Deng F; Wu J; Geng S; Xie C; Zhong C
    J Cell Biochem; 2019 Sep; 120(9):15616-15624. PubMed ID: 31042325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hypoxia-induced microRNA-130a controls pulmonary smooth muscle cell proliferation by directly targeting CDKN1A.
    Brock M; Haider TJ; Vogel J; Gassmann M; Speich R; Trenkmann M; Ulrich S; Kohler M; Huber LC
    Int J Biochem Cell Biol; 2015 Apr; 61():129-37. PubMed ID: 25681685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Curcumin inhibits the expression of vascular endothelial growth factor and androgen-independent prostate cancer cell line PC-3 in vitro].
    Deng G; Yu JH; Ye ZQ; Hu ZQ
    Zhonghua Nan Ke Xue; 2008 Feb; 14(2):116-21. PubMed ID: 18390174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-17/106b seed family regulates p21 in Hodgkin's lymphoma.
    Gibcus JH; Kroesen BJ; Koster R; Halsema N; de Jong D; de Jong S; Poppema S; Kluiver J; Diepstra A; van den Berg A
    J Pathol; 2011 Dec; 225(4):609-17. PubMed ID: 21953646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma.
    Szczyrba J; Nolte E; Wach S; Kremmer E; Stöhr R; Hartmann A; Wieland W; Wullich B; Grässer FA
    Mol Cancer Res; 2011 Jun; 9(6):791-800. PubMed ID: 21593139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2.
    Fornari F; Milazzo M; Chieco P; Negrini M; Marasco E; Capranico G; Mantovani V; Marinello J; Sabbioni S; Callegari E; Cescon M; Ravaioli M; Croce CM; Bolondi L; Gramantieri L
    J Pathol; 2012 Jul; 227(3):275-85. PubMed ID: 22262409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-93 promotes ovarian granulosa cells proliferation through targeting CDKN1A in polycystic ovarian syndrome.
    Jiang L; Huang J; Li L; Chen Y; Chen X; Zhao X; Yang D
    J Clin Endocrinol Metab; 2015 May; 100(5):E729-38. PubMed ID: 25695884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive characterization of the effects of ellagic acid and urolithins on colorectal cancer and key-associated molecular hallmarks: MicroRNA cell specific induction of CDKN1A (p21) as a common mechanism involved.
    González-Sarrías A; Núñez-Sánchez MÁ; Tomé-Carneiro J; Tomás-Barberán FA; García-Conesa MT; Espín JC
    Mol Nutr Food Res; 2016 Apr; 60(4):701-16. PubMed ID: 26634414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-96 promotes the growth of prostate carcinoma cells by suppressing MTSS1.
    Xu L; Zhong J; Guo B; Zhu Q; Liang H; Wen N; Yun W; Zhang L
    Tumour Biol; 2016 Sep; 37(9):12023-12032. PubMed ID: 27164937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-proliferative potential of curcumin in androgen-dependent prostate cancer cells occurs through modulation of the Wingless signaling pathway.
    Teiten MH; Gaascht F; Cronauer M; Henry E; Dicato M; Diederich M
    Int J Oncol; 2011 Mar; 38(3):603-11. PubMed ID: 21240460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-218 inhibits prostate cancer cell growth and promotes apoptosis by repressing TPD52 expression.
    Han G; Fan M; Zhang X
    Biochem Biophys Res Commun; 2015 Jan; 456(3):804-9. PubMed ID: 25511701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin inhibits oral squamous cell carcinoma SCC-9 cells proliferation by regulating miR-9 expression.
    Xiao C; Wang L; Zhu L; Zhang C; Zhou J
    Biochem Biophys Res Commun; 2014 Nov; 454(4):576-80. PubMed ID: 25450696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equol inhibits proliferation of human gastric carcinoma cells via modulating Akt pathway.
    Yang ZP; Zhao Y; Huang F; Chen J; Yao YH; Li J; Wu XN
    World J Gastroenterol; 2015 Sep; 21(36):10385-99. PubMed ID: 26420965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.